AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medicus Pharma Ltd. Director's Dealing 2025

May 21, 2025

34562_dirs_2025-05-21_45496892-0276-4f85-9465-8e4ac29818ee.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Medicus Pharma Ltd. (MDCX)
CIK: 0001997296
Period of Report: 2024-12-31

Reporting Person: VELOCITY FUND PARTNERS, LP (10% Owner)
Reporting Person: Melani Kenneth R. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares, no par value ("Common Shares")	2914330	Indirect
Common Shares	409411	Direct

Footnotes

F1: Held by Velocity Fund Partners, LP, an entity controlled by Dr. Kenneth R. Melani. Dr. Kenneth R. Melani disclaims beneficial ownership except to the extent of his pecuniary interest therein.